Should we treat acute respiratory distress syndrome with inhaled nitric oxide?

Lancet

Volumn 350, Issue 9071, 1997, Pages 111-112

  Troncy, Eric ^a,b   Collet, Jean Paul ^a   Shapiro, Stan ^a   Guimond, Jean Gilles ^a   Blair, Louis ^a   Charbonneau, Marc ^a   Blaise, Gilbert ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INORGANIC COMPOUND; NITRIC OXIDE;

ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GAS EXCHANGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0030841342     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)24028-6     Document Type: Article

References (4)

1. Rossaint R, Falke KJ, López FA, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
2. Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19: 443-49.
3. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
4. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-23.